Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-33.10	17.15	25.63
Graham Fair Price	302.16	27.28	6.78
PEG	-99.60	< 0.005	-1.20
Price/Book	-3.38	1.09	1.13
Price/Cash Flow	-47.31	22.60	42.90
Prices/Earnings	-93.80	6.89	111.16
Price/Sales	6.49	2.88	2.70
Price/FCF	-47.31	22.60	42.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	63.03	0.17	0.10
Operating Margin	153.23	0.12	0.05
ROA	1474.26	0.02	< 0.005
ROE	< 0.005	0.04	1458.22
ROIC	< 0.005	0.02	452.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-117.40
Dividends QOQ	0.03	0.02	-16.62
EBIT QOQ	-0.70	1.30	84.70
EPS QOQ	-0.93	14.36	1449.08
FCF QOQ	-0.31	0.83	170.73
Revenue QOQ	0.02	-0.09	426.58
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	33.51	40.47	20.78
Days Sales Outstanding (DSO)	61.63	67.82	10.04
Inventory Turnover	2.69	2.22	-17.20
Debt/Capitalization	0.24	0.22	-7.21
Quick Ratio	0.96	0.99	3.17
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28.41	28.95	1.88
Cash	5.90	6.20	4.99
Capex	-1.08	-0.62	43.20
Free Cash Flow	0.75	1.39	86.83
Revenue	11.85	10.95	-7.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.40	1.41	0.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.33	2.82	-34.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating